
The global Entrectinib market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Entrectinib, also known as RXDX-101 and NMS-E628, is an oral small molecule inhibitor of TrkA, TrkB and TrkC, as well as ROS1 and ALK, with high potency and selectivity. RXDX-101 has demonstrated potent pharmacological activity in preclinical studies and has the potential to be first-in-class against the Trk family of kinases. PXDX-101 has been well tolerated in patients with advanced solid tumors. PXDX-101 is currently in clinical trials, and is being developed by Ignyta.
This report is a detailed and comprehensive analysis for global Entrectinib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Entrectinib market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Entrectinib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Entrectinib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Entrectinib market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Entrectinib
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Entrectinib market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BOCSCI, APExBIO Technology, Cayman Chemical, ChemScence, Crysdot, Medical Isotopes, TargetMol Chemicals, Toronto Research Chemicals, Beijing Jingming Biotechnology, Cool Pharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Entrectinib market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0.99
0.98
Market segment by Application
Anaplastic Lymphoma
C-ros Oncogene
Major players covered
BOCSCI
APExBIO Technology
Cayman Chemical
ChemScence
Crysdot
Medical Isotopes
TargetMol Chemicals
Toronto Research Chemicals
Beijing Jingming Biotechnology
Cool Pharm
Shanghai Lollane Biological Technology
Shanghai Macklin Biochemical
Shanghai Muse Health Tech
ATK Chemical
Shanghai Send Pharmaceutical Technology
Shanghai Yuanye Bio-Technology
Wuhan Sun-Shine Bio-Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Entrectinib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Entrectinib, with price, sales quantity, revenue, and global market share of Entrectinib from 2020 to 2025.
Chapter 3, the Entrectinib competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Entrectinib breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Entrectinib market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Entrectinib.
Chapter 14 and 15, to describe Entrectinib sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Entrectinib Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 0.99
1.3.3 0.98
1.4 Market Analysis by Application
1.4.1 Overview: Global Entrectinib Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Anaplastic Lymphoma
1.4.3 C-ros Oncogene
1.5 Global Entrectinib Market Size & Forecast
1.5.1 Global Entrectinib Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Entrectinib Sales Quantity (2020-2031)
1.5.3 Global Entrectinib Average Price (2020-2031)
2 Manufacturers Profiles
2.1 BOCSCI
2.1.1 BOCSCI Details
2.1.2 BOCSCI Major Business
2.1.3 BOCSCI Entrectinib Product and Services
2.1.4 BOCSCI Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 BOCSCI Recent Developments/Updates
2.2 APExBIO Technology
2.2.1 APExBIO Technology Details
2.2.2 APExBIO Technology Major Business
2.2.3 APExBIO Technology Entrectinib Product and Services
2.2.4 APExBIO Technology Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 APExBIO Technology Recent Developments/Updates
2.3 Cayman Chemical
2.3.1 Cayman Chemical Details
2.3.2 Cayman Chemical Major Business
2.3.3 Cayman Chemical Entrectinib Product and Services
2.3.4 Cayman Chemical Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Cayman Chemical Recent Developments/Updates
2.4 ChemScence
2.4.1 ChemScence Details
2.4.2 ChemScence Major Business
2.4.3 ChemScence Entrectinib Product and Services
2.4.4 ChemScence Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 ChemScence Recent Developments/Updates
2.5 Crysdot
2.5.1 Crysdot Details
2.5.2 Crysdot Major Business
2.5.3 Crysdot Entrectinib Product and Services
2.5.4 Crysdot Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Crysdot Recent Developments/Updates
2.6 Medical Isotopes
2.6.1 Medical Isotopes Details
2.6.2 Medical Isotopes Major Business
2.6.3 Medical Isotopes Entrectinib Product and Services
2.6.4 Medical Isotopes Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Medical Isotopes Recent Developments/Updates
2.7 TargetMol Chemicals
2.7.1 TargetMol Chemicals Details
2.7.2 TargetMol Chemicals Major Business
2.7.3 TargetMol Chemicals Entrectinib Product and Services
2.7.4 TargetMol Chemicals Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 TargetMol Chemicals Recent Developments/Updates
2.8 Toronto Research Chemicals
2.8.1 Toronto Research Chemicals Details
2.8.2 Toronto Research Chemicals Major Business
2.8.3 Toronto Research Chemicals Entrectinib Product and Services
2.8.4 Toronto Research Chemicals Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Toronto Research Chemicals Recent Developments/Updates
2.9 Beijing Jingming Biotechnology
2.9.1 Beijing Jingming Biotechnology Details
2.9.2 Beijing Jingming Biotechnology Major Business
2.9.3 Beijing Jingming Biotechnology Entrectinib Product and Services
2.9.4 Beijing Jingming Biotechnology Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Beijing Jingming Biotechnology Recent Developments/Updates
2.10 Cool Pharm
2.10.1 Cool Pharm Details
2.10.2 Cool Pharm Major Business
2.10.3 Cool Pharm Entrectinib Product and Services
2.10.4 Cool Pharm Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Cool Pharm Recent Developments/Updates
2.11 Shanghai Lollane Biological Technology
2.11.1 Shanghai Lollane Biological Technology Details
2.11.2 Shanghai Lollane Biological Technology Major Business
2.11.3 Shanghai Lollane Biological Technology Entrectinib Product and Services
2.11.4 Shanghai Lollane Biological Technology Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Shanghai Lollane Biological Technology Recent Developments/Updates
2.12 Shanghai Macklin Biochemical
2.12.1 Shanghai Macklin Biochemical Details
2.12.2 Shanghai Macklin Biochemical Major Business
2.12.3 Shanghai Macklin Biochemical Entrectinib Product and Services
2.12.4 Shanghai Macklin Biochemical Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Shanghai Macklin Biochemical Recent Developments/Updates
2.13 Shanghai Muse Health Tech
2.13.1 Shanghai Muse Health Tech Details
2.13.2 Shanghai Muse Health Tech Major Business
2.13.3 Shanghai Muse Health Tech Entrectinib Product and Services
2.13.4 Shanghai Muse Health Tech Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Shanghai Muse Health Tech Recent Developments/Updates
2.14 ATK Chemical
2.14.1 ATK Chemical Details
2.14.2 ATK Chemical Major Business
2.14.3 ATK Chemical Entrectinib Product and Services
2.14.4 ATK Chemical Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 ATK Chemical Recent Developments/Updates
2.15 Shanghai Send Pharmaceutical Technology
2.15.1 Shanghai Send Pharmaceutical Technology Details
2.15.2 Shanghai Send Pharmaceutical Technology Major Business
2.15.3 Shanghai Send Pharmaceutical Technology Entrectinib Product and Services
2.15.4 Shanghai Send Pharmaceutical Technology Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Shanghai Send Pharmaceutical Technology Recent Developments/Updates
2.16 Shanghai Yuanye Bio-Technology
2.16.1 Shanghai Yuanye Bio-Technology Details
2.16.2 Shanghai Yuanye Bio-Technology Major Business
2.16.3 Shanghai Yuanye Bio-Technology Entrectinib Product and Services
2.16.4 Shanghai Yuanye Bio-Technology Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Shanghai Yuanye Bio-Technology Recent Developments/Updates
2.17 Wuhan Sun-Shine Bio-Technology
2.17.1 Wuhan Sun-Shine Bio-Technology Details
2.17.2 Wuhan Sun-Shine Bio-Technology Major Business
2.17.3 Wuhan Sun-Shine Bio-Technology Entrectinib Product and Services
2.17.4 Wuhan Sun-Shine Bio-Technology Entrectinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Wuhan Sun-Shine Bio-Technology Recent Developments/Updates
3 Competitive Environment: Entrectinib by Manufacturer
3.1 Global Entrectinib Sales Quantity by Manufacturer (2020-2025)
3.2 Global Entrectinib Revenue by Manufacturer (2020-2025)
3.3 Global Entrectinib Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Entrectinib by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Entrectinib Manufacturer Market Share in 2024
3.4.3 Top 6 Entrectinib Manufacturer Market Share in 2024
3.5 Entrectinib Market: Overall Company Footprint Analysis
3.5.1 Entrectinib Market: Region Footprint
3.5.2 Entrectinib Market: Company Product Type Footprint
3.5.3 Entrectinib Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Entrectinib Market Size by Region
4.1.1 Global Entrectinib Sales Quantity by Region (2020-2031)
4.1.2 Global Entrectinib Consumption Value by Region (2020-2031)
4.1.3 Global Entrectinib Average Price by Region (2020-2031)
4.2 North America Entrectinib Consumption Value (2020-2031)
4.3 Europe Entrectinib Consumption Value (2020-2031)
4.4 Asia-Pacific Entrectinib Consumption Value (2020-2031)
4.5 South America Entrectinib Consumption Value (2020-2031)
4.6 Middle East & Africa Entrectinib Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Entrectinib Sales Quantity by Type (2020-2031)
5.2 Global Entrectinib Consumption Value by Type (2020-2031)
5.3 Global Entrectinib Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Entrectinib Sales Quantity by Application (2020-2031)
6.2 Global Entrectinib Consumption Value by Application (2020-2031)
6.3 Global Entrectinib Average Price by Application (2020-2031)
7 North America
7.1 North America Entrectinib Sales Quantity by Type (2020-2031)
7.2 North America Entrectinib Sales Quantity by Application (2020-2031)
7.3 North America Entrectinib Market Size by Country
7.3.1 North America Entrectinib Sales Quantity by Country (2020-2031)
7.3.2 North America Entrectinib Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Entrectinib Sales Quantity by Type (2020-2031)
8.2 Europe Entrectinib Sales Quantity by Application (2020-2031)
8.3 Europe Entrectinib Market Size by Country
8.3.1 Europe Entrectinib Sales Quantity by Country (2020-2031)
8.3.2 Europe Entrectinib Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Entrectinib Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Entrectinib Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Entrectinib Market Size by Region
9.3.1 Asia-Pacific Entrectinib Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Entrectinib Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Entrectinib Sales Quantity by Type (2020-2031)
10.2 South America Entrectinib Sales Quantity by Application (2020-2031)
10.3 South America Entrectinib Market Size by Country
10.3.1 South America Entrectinib Sales Quantity by Country (2020-2031)
10.3.2 South America Entrectinib Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Entrectinib Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Entrectinib Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Entrectinib Market Size by Country
11.3.1 Middle East & Africa Entrectinib Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Entrectinib Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Entrectinib Market Drivers
12.2 Entrectinib Market Restraints
12.3 Entrectinib Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Entrectinib and Key Manufacturers
13.2 Manufacturing Costs Percentage of Entrectinib
13.3 Entrectinib Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Entrectinib Typical Distributors
14.3 Entrectinib Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
BOCSCI
APExBIO Technology
Cayman Chemical
ChemScence
Crysdot
Medical Isotopes
TargetMol Chemicals
Toronto Research Chemicals
Beijing Jingming Biotechnology
Cool Pharm
Shanghai Lollane Biological Technology
Shanghai Macklin Biochemical
Shanghai Muse Health Tech
ATK Chemical
Shanghai Send Pharmaceutical Technology
Shanghai Yuanye Bio-Technology
Wuhan Sun-Shine Bio-Technology
Ìý
Ìý
*If Applicable.
